U.S. federal trademark · Serial No. 90288233 · Reg. No. 6828605
Pharmaceutical preparations, in liquid form and containing tasimelteon, for use in the treatment of diseases and disorders of the central nervous system, diseases and disorders having an impact on the central nervous system, diseases and disorders having a central nervous system manifestation, diseases and disorders of the circadian rhythm, diseases and disorders having an impact on circadian rhythm, and diseases and disorders having a circadian rhythm manifestation
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.